Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe diseaseYoav H. Messinger, Priya S. Kishnani, Sarah P. Young et al.|Genetics in Medicine|2012Cited by 212
Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and GenomicsJ. Daniel Sharer, Sarah P. Young, Olaf A. Bodamer et al.|Genetics in Medicine|2017Cited by 38
Early initiation of enzyme replacement therapy as facilitated by newborn screening improves health outcomes among patients with infantile-onset Pompe diseaseAnkit K. Desai, Priya S. Kishnani, Eleanor Rodriguez-Rassi et al.|Genetics in Medicine Open|2025Cited by 1
74. Immunological aspects of treatment of Pompe diseasePriya S. Kishnani, Y.T. Chen, Suhrad G. Banugaria et al.|Molecular Genetics and Metabolism|2010Cited by 0
Rationally Designed Potent and Selective CK1α Degraders Exert Antiproliferative Activity Against a Broad Range of Human Cancer Cell LinesZoran Ranković, Anthony A. High, Gisele Nishiguchi et al.|Research Square|2023Cited by 0